Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Kir2.1 blockers(potassium inwardly rectifying channel subfamily J member 2 blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H19NO |
InChIKeyGIFYKGIODMXYNT-UHFFFAOYSA-N |
CAS Registry185669-79-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Diseases | Preclinical | US | 25 Mar 2011 |